UnitedHealth vs Johnson & Johnson: financial comparison Compare UnitedHealth and Johnson & Johnson side by side: valuation, margins, growth, cash and dividends, with the quarterly history of both. Yahoo Finance data, free and no sign-up.
UnitedHealth vs Johnson & Johnson: key metrics UnitedHealthUSD Johnson & JohnsonUSD Valuation Market cap 332.87 B USD 645.19 B USD P/E (TTM) 23.85 31.09 Forward P/E 16.40 22.06 Price / Sales 0.74 6.59 EV / EBITDA 14.40 19.41 Price / Book 3.41 7.59 Margins & growth Profit margin +3.14% +21.48% Operating margin +7.13% +29.19% Quarterly revenue (YoY) — +6.6% Quarterly earnings (YoY) — -0.05% Cash flow FCF yield +7.29% +2.62% Stock-based compensation — — Balance Cash 31.47 B USD 20.76 B USD Debt 73.33 B USD 49.04 B USD Net position -41.86 B USD -28.28 B USD Dividend Dividend yield +2.49% +1.99% Payout ratio +57.52% +60.79%
Each column shows figures in that company's reporting currency (shown in the header); they are not converted. Ratios and percentages are currency-independent.
Price, rebased to 100 UnitedHealth91 Johnson & Johnson163
50 100 150 2021 2026 P/E (TTM) UnitedHealth23.9× Johnson & Johnson31.0×
10 20 30 40 2021 2026 Both curves start at 100 on the same day, so this compares returns rather than prices. Each week's P/E is the price divided by the earnings per share already reported by that date; loss-making weeks are not drawn.
What analysts expect Consensus revenue and earnings per share for the periods not yet reported.
Quarterly Annual
Revenue forecast · UnitedHealth Reported Estimate⤢
0 50B 100B Q3 25: 113.16 B USD Q3 25 Q4 25: 113.22 B USD Q4 25 Q1 26: 111.72 B USD Q1 26 Q2 26: 112.03 B USD Q2 26 Q3 26 · Estimate: 111.49 B USD (108.49 B USD – 114.00 B USD) Q3 26 Q4 26 · Estimate: 111.28 B USD (107.27 B USD – 115.00 B USD) Q4 26 USD Consensus of 18 analysts for Q3 26 · -1.48% year on year
Revenue forecast · Johnson & Johnson Reported Estimate⤢
0 10B 20B Q3 25: 23.99 B USD Q3 25 Q4 25: 24.56 B USD Q4 25 Q1 26: 24.06 B USD Q1 26 Q2 26: 25.31 B USD Q2 26 Q3 26 · Estimate: 25.29 B USD (25.04 B USD – 25.70 B USD) Q3 26 Q4 26 · Estimate: 26.51 B USD (26.31 B USD – 26.78 B USD) Q4 26 USD Consensus of 6 analysts for Q3 26 · +5.41% year on year
EPS forecast · UnitedHealth Reported Estimate⤢
0 2 4 6 Q3 25: 2.92 · expected 2.81 (+3.99%) Q3 25 Q4 25: 2.11 · expected 2.11 (+0.19%) Q4 25 Q1 26: 7.23 · expected 6.60 (+9.52%) Q1 26 Q2 26: 6.38 · expected 4.92 (+29.8%) Q2 26 Q3 26 · Estimate: 4.15 (3.90 – 4.56) Q3 26 Q4 26 · Estimate: 2.10 (1.64 – 2.53) Q4 26 Consensus of 23 analysts for Q3 26 · +42.1% year on year · adjusted earnings
EPS forecast · Johnson & Johnson Reported Estimate⤢
0 1 2 3 Q3 25: 2.80 · expected 2.76 (+1.49%) Q3 25 Q4 25: 2.46 · expected 2.46 (-0.11%) Q4 25 Q1 26: 2.70 · expected 2.68 (+0.85%) Q1 26 Q2 26: 2.90 · expected 2.85 (+1.58%) Q2 26 Q3 26 · Estimate: 2.45 (2.31 – 2.66) Q3 26 Q4 26 · Estimate: 2.97 (2.74 – 3.13) Q4 26 Consensus of 6 analysts for Q3 26 · -12.38% year on year · adjusted earnings
Analyst consensus from Yahoo Finance. The dashed bar is the average and the whisker runs from the lowest analyst to the highest. On periods already reported, the green or red line marks what had been expected: below the bar means the company beat it. EPS is measured on an adjusted basis, which is what analysts forecast against and is not the accounting profit in the statements.
Compared over time Quarterly Annual
Revenue UnitedHealth Johnson & Johnson
0 50B 100B Q3 22 · UnitedHealth: 80.89 B USD Q3 22 · Johnson & Johnson: 20.22 B USD Q3 22 Q4 22 · UnitedHealth: 82.79 B USD Q4 22 · Johnson & Johnson: 20.00 B USD Q1 23 · UnitedHealth: 91.93 B USD Q1 23 · Johnson & Johnson: 19.94 B USD Q2 23 · UnitedHealth: 92.90 B USD Q2 23 · Johnson & Johnson: 20.89 B USD Q2 23 Q3 23 · UnitedHealth: 92.36 B USD Q3 23 · Johnson & Johnson: 21.52 B USD Q4 23 · UnitedHealth: 94.43 B USD Q4 23 · Johnson & Johnson: 21.40 B USD Q1 24 · UnitedHealth: 99.80 B USD Q1 24 · Johnson & Johnson: 21.38 B USD Q1 24 Q2 24 · UnitedHealth: 98.86 B USD Q2 24 · Johnson & Johnson: 22.45 B USD Q3 24 · UnitedHealth: 100.82 B USD Q3 24 · Johnson & Johnson: 22.47 B USD Q4 24 · Johnson & Johnson: 22.52 B USD Q4 24 Q1 25 · Johnson & Johnson: 21.89 B USD Q2 25 · UnitedHealth: 111.62 B USD Q2 25 · Johnson & Johnson: 23.74 B USD Q3 25 · UnitedHealth: 113.16 B USD Q3 25 · Johnson & Johnson: 23.99 B USD Q3 25 Q4 25 · UnitedHealth: 113.22 B USD Q4 25 · Johnson & Johnson: 24.56 B USD Q1 26 · UnitedHealth: 111.72 B USD Q1 26 · Johnson & Johnson: 24.06 B USD Q2 26 · UnitedHealth: 112.03 B USD Q2 26 · Johnson & Johnson: 25.31 B USD Q2 26 USD Net income UnitedHealth Johnson & Johnson
0 5B 10B Q3 22 · UnitedHealth: 5.26 B USD Q3 22 · Johnson & Johnson: 4.81 B USD Q3 22 Q4 22 · UnitedHealth: 4.76 B USD Q4 22 · Johnson & Johnson: 4.46 B USD Q1 23 · UnitedHealth: 5.61 B USD Q1 23 · Johnson & Johnson: 3.52 B USD Q2 23 · UnitedHealth: 5.47 B USD Q2 23 · Johnson & Johnson: -68.00 M USD Q2 23 Q3 23 · UnitedHealth: 5.84 B USD Q3 23 · Johnson & Johnson: 5.14 B USD Q4 23 · UnitedHealth: 5.46 B USD Q4 23 · Johnson & Johnson: 4.05 B USD Q1 24 · UnitedHealth: -1.41 B USD Q1 24 · Johnson & Johnson: 3.26 B USD Q1 24 Q2 24 · UnitedHealth: 4.22 B USD Q2 24 · Johnson & Johnson: 4.69 B USD Q3 24 · UnitedHealth: 6.06 B USD Q3 24 · Johnson & Johnson: 2.69 B USD Q4 24 · Johnson & Johnson: 3.43 B USD Q4 24 Q1 25 · Johnson & Johnson: 11.00 B USD Q2 25 · UnitedHealth: 3.41 B USD Q2 25 · Johnson & Johnson: 5.54 B USD Q3 25 · UnitedHealth: 2.35 B USD Q3 25 · Johnson & Johnson: 5.15 B USD Q3 25 Q4 25 · UnitedHealth: 10.00 M USD Q4 25 · Johnson & Johnson: 5.12 B USD Q1 26 · UnitedHealth: 6.28 B USD Q1 26 · Johnson & Johnson: 5.24 B USD Q2 26 · UnitedHealth: 5.48 B USD Q2 26 · Johnson & Johnson: 5.53 B USD Q2 26 USD Free cash flow UnitedHealth Johnson & Johnson
0 10B Q3 22 · UnitedHealth: 17.83 B USD Q3 22 · Johnson & Johnson: 4.72 B USD Q3 22 Q4 22 · UnitedHealth: -5.40 B USD Q4 22 · Johnson & Johnson: 5.33 B USD Q1 23 · UnitedHealth: 15.57 B USD Q1 23 · Johnson & Johnson: 3.76 B USD Q2 23 · UnitedHealth: 10.20 B USD Q2 23 · Johnson & Johnson: 2.39 B USD Q2 23 Q3 23 · UnitedHealth: 6.06 B USD Q3 23 · Johnson & Johnson: 3.06 B USD Q4 23 · UnitedHealth: -6.15 B USD Q4 23 · Johnson & Johnson: 6.27 B USD Q1 24 · UnitedHealth: 401.00 M USD Q1 24 · Johnson & Johnson: 2.85 B USD Q1 24 Q2 24 · UnitedHealth: 5.89 B USD Q2 24 · Johnson & Johnson: 4.66 B USD Q3 24 · UnitedHealth: 12.95 B USD Q3 24 · Johnson & Johnson: 6.96 B USD Q4 24 · Johnson & Johnson: 5.37 B USD Q4 24 Q1 25 · Johnson & Johnson: 3.38 B USD Q2 25 · UnitedHealth: 6.30 B USD Q2 25 · Johnson & Johnson: 2.48 B USD Q3 25 · UnitedHealth: 5.06 B USD Q3 25 · Johnson & Johnson: 8.00 B USD Q3 25 Q4 25 · UnitedHealth: 160.00 M USD Q4 25 · Johnson & Johnson: 5.47 B USD Q1 26 · UnitedHealth: 8.15 B USD Q1 26 · Johnson & Johnson: 1.47 B USD Q2 26 · UnitedHealth: 10.25 B USD Q2 26 · Johnson & Johnson: 7.30 B USD Q2 26 USD EPS UnitedHealth Johnson & Johnson
0 2.5 5 Q3 22 · UnitedHealth: 5.55 Q3 22 · Johnson & Johnson: 1.80 Q3 22 Q4 22 · UnitedHealth: 5.02 Q4 22 · Johnson & Johnson: 1.68 Q1 23 · UnitedHealth: 5.95 Q1 23 · Johnson & Johnson: 1.33 Q2 23 · UnitedHealth: 5.82 Q2 23 · Johnson & Johnson: -0.03 Q2 23 Q3 23 · UnitedHealth: 6.24 Q3 23 · Johnson & Johnson: 1.96 Q4 23 · UnitedHealth: 5.85 Q4 23 · Johnson & Johnson: 1.67 Q1 24 · UnitedHealth: -1.53 Q1 24 · Johnson & Johnson: 1.34 Q1 24 Q2 24 · UnitedHealth: 4.54 Q2 24 · Johnson & Johnson: 1.93 Q3 24 · UnitedHealth: 6.51 Q3 24 · Johnson & Johnson: 1.11 Q4 24 · Johnson & Johnson: 1.41 Q4 24 Q1 25 · Johnson & Johnson: 4.54 Q2 25 · UnitedHealth: 3.74 Q2 25 · Johnson & Johnson: 2.29 Q3 25 · UnitedHealth: 2.59 Q3 25 · Johnson & Johnson: 2.12 Q3 25 Q4 25 · UnitedHealth: 0.01 Q4 25 · Johnson & Johnson: 2.10 Q1 26 · UnitedHealth: 6.90 Q1 26 · Johnson & Johnson: 2.14 Q2 26 · UnitedHealth: 6.04 Q2 26 · Johnson & Johnson: 2.27 Q2 26 EBITDA UnitedHealth Johnson & Johnson
0 5B 10B 15B Q3 22 · UnitedHealth: 8.29 B USD Q3 22 · Johnson & Johnson: 7.62 B USD Q3 22 Q4 22 · UnitedHealth: 7.87 B USD Q4 22 · Johnson & Johnson: 7.06 B USD Q1 23 · UnitedHealth: 9.06 B USD Q1 23 · Johnson & Johnson: 6.08 B USD Q2 23 · UnitedHealth: 9.08 B USD Q2 23 · Johnson & Johnson: 1.23 B USD Q2 23 Q3 23 · UnitedHealth: 9.53 B USD Q3 23 · Johnson & Johnson: 8.35 B USD Q4 23 · UnitedHealth: 8.66 B USD Q4 23 · Johnson & Johnson: 6.74 B USD Q1 24 · UnitedHealth: 8.93 B USD Q1 24 · Johnson & Johnson: 5.68 B USD Q1 24 Q2 24 · UnitedHealth: 8.90 B USD Q2 24 · Johnson & Johnson: 7.80 B USD Q3 24 · UnitedHealth: 9.75 B USD Q3 24 · Johnson & Johnson: 5.38 B USD Q4 24 · Johnson & Johnson: 5.92 B USD Q4 24 Q1 25 · Johnson & Johnson: 15.61 B USD Q2 25 · UnitedHealth: 6.19 B USD Q2 25 · Johnson & Johnson: 8.74 B USD Q3 25 · UnitedHealth: 5.33 B USD Q3 25 · Johnson & Johnson: 9.52 B USD Q3 25 Q4 25 · UnitedHealth: 1.37 B USD Q4 25 · Johnson & Johnson: 7.19 B USD Q1 26 · UnitedHealth: 9.95 B USD Q1 26 · Johnson & Johnson: 8.27 B USD Q2 26 · UnitedHealth: 8.97 B USD Q2 26 · Johnson & Johnson: 8.99 B USD Q2 26 USD Source: Yahoo Finance. Quarterly history grows automatically over time as new quarters are published.